Welcome to Greenshoots
Greenshoots is a collection of fresh intellectual property insight, analysis and commentary on the issues that matter most to those who invent, manage and protect intellectual property, written by the IP specialists of Appleyard Lees.
Now that you’re here, why not take a look around?
Exhaustion regime post-Brexit – A new UK consultation
The Brexit transition period came to an end on 31 December 2020 and as of 1 January 2021 the UK was no longer bound by EU legal framework. Before the UK left the EU, the UK was party to the EU’s regional exhaustion of IP rights regime.
Directors and IP – getting up close and personal
The received wisdom is that company directors can escape liability by sheltering behind the “corporate veil”. But is this true in IP cases?
Is it worth patenting your AI tools for drug discovery?
Often, when the AI identifies a drug, and experiments confirm it is useful for the intended purpose, the drug can be patented. But what about the AI itself – can the AI be protected by patents, and should you try to?
Intellectual property for start-ups in a post-COVID world: part five – managing know-how and trade secrets
This series of articles explores the effect of COVID-19-related disruption on start-ups’ management and monetisation
The Greenshoots Podcast by Appleyard Lees – episode 16: the entrepreneurial journey of Mags Walker, founder of the fabl and Toolally.
Serial entrepreneur Mags Walker joins Appleyard Lees partner and solicitor Chris Hoole to talk about
Tech transfer teams’ IP challenges post-COVID-19 and beyond: part five, emerging trends for UK spin-outs and leveraging IP for funding
Part five, emerging trends for UK spin-outs and leveraging IP for funding In part five
Intellectual property for start-ups in a post-COVID world: part four – patenting software
This series of articles explores the effect of COVID-19-related disruption on start-ups’ management and monetisation
Someone’s copying my invention! What should I do?
What do you do if, before you have obtained a granted patent, a third party starts selling a product that looks like your invention? Is there anything you can do to stop the third party? Does your patent application provide you with any rights before the patent is granted? Parminder Lally and Simon Ambroz answer these questions.
Intellectual property for start-ups in a post-COVID world: part three – managing commercial IP
This series of articles explores the effect of COVID-19-related disruption on start-ups’ management and monetisation
